This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Conan Wang, PhD
Senior Research Officer, Institute for Molecular Bioscience at University of Queensland


Dr Conan Wang is an ARC Future Fellow. He is located at the Institute for Molecular Bioscience (IMB), UQ, and withing the ARC CoE for Innovations in Peptide and Protein Science. He obtained his PhD on characterisation of circular peptides (2009), and then was awarded a NHMRC Early Career Fellowship to study protein structure at the Hong Kong University of Science and Technology and Griffith University Eskitis Institute. His current focus is on the design of cyclic peptides to inhibit protein-protein interactions, particularly for targets in immuno-oncology. He has authored over 90 publications on peptide design and delivery as well as on protein structure and function, which have received more than 4700 citations. His scientific achievements have been recognised by 28 national and international prizes and travel awards, including from Griffith University and the Australian Society for Medical Research, and presented at over 30 national and international conferences.

Agenda Sessions

  • Cyclic and Disulfide-rich Peptide Permeability, Penetration and Inhibition of Protein-protein Interactions